StockWatch
·
Surgical & Medical Instruments & Apparatus
Quarterly ResultMay 15, 2026, 04:38 PM

Allurion Q1 Net Loss Widens to $6.1M; Going Concern Doubt

AI Summary

Allurion Technologies reported a wider net loss of $6.1 million for the first quarter of 2026, compared to $1.5 million in the same period last year, with revenue decreasing significantly to $2.9 million from $5.6 million. The company also disclosed substantial doubt about its ability to continue as a going concern due to recurring losses, negative operating cash flows, and non-compliance with certain financial covenants. Despite an improved loss from operations and reduced cash used in operating activities, the overall financial position deteriorated.

Key Highlights

  • Allurion disclosed substantial doubt about its ability to continue as a going concern.
  • Net loss widened to $6.1 million in Q1 2026 from $1.5 million in Q1 2025.
  • Revenue decreased 47.2% to $2.9 million in Q1 2026 from $5.6 million in Q1 2025.
  • Loss from operations improved to $(3.7) million in Q1 2026 from $(7.3) million in Q1 2025.
  • Net cash used in operating activities improved to $(3.2) million from $(9.5) million.
  • Cash and cash equivalents stood at $5.1 million as of March 31, 2026.
  • Total stockholders' deficit increased to $(77.9) million.
  • RTW Convertible Notes principal amount was $43.5 million.